| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196092 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196078 Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7196075 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 03/27/2007 | US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | CA2399976C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2247520C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 03/27/2007 | CA2168879C Skin patches and methods for providing testosterone |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2006134385A3 Anti-inflammatory agents |
| 03/22/2007 | WO2006016424A8 Preventive and/or therapeutic agent for calcipenia |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066685 culturing propionibacterium under anaerobic conditions, in medium containing a carbon source such as lactose, to form 1,4-dihydroxynaphthalene-2-carboxylic acid, having a good flavor, useful for foods, beverages and drugs |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066614 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065493 External patch containing estrogen and/or progestogen |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622322A1 Bisphosphonate formulation |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764413A1 Protein preparation containing s1-5 |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764367A1 Thienopyridine derivatives |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764091A2 Improvements in or relating to amphoteric liposomes |
| 03/21/2007 | EP1763516A2 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 03/21/2007 | EP1763515A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 03/21/2007 | EP1763362A1 Use of morphogenic proteins for treating cartilage defects |
| 03/21/2007 | EP1763361A2 Steroid sparing agents and their use |
| 03/21/2007 | EP1763355A1 Use of composition comrising d-mannoheptulose and/or perseitol for the treatment and prevention of diseases linked to a modification of the innate immunity |
| 03/21/2007 | EP1763353A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR |
| 03/21/2007 | EP1675608B1 Injectable calcium phosphate solid rods for delivery of osteogenic proteins |
| 03/21/2007 | EP1517703B1 Placental growth factor as a target for the treatment of osteoporosis |
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
| 03/21/2007 | EP1385492B1 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis |
| 03/21/2007 | EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1216024B1 Formulation for menopausal women |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1049717B1 Antibodies against human il-12 |
| 03/21/2007 | EP0865446B1 Agents for promoting bone formation |
| 03/21/2007 | CN1934122A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934111A Heteroaryl-fused pyrazolo derivatives |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 03/21/2007 | CN1933848A Y2 selective receptor agonists for therapeutic interventions |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/21/2007 | CN1931359A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931358A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931355A Arthritis treating and swelling eliminating medicine powder |
| 03/21/2007 | CN1931353A Curcuma extract and its prepn process, medicine composition and use |
| 03/21/2007 | CN1931339A Medicine for treating osteoporosis and its production process |
| 03/21/2007 | CN1931328A Multifunctional paster |
| 03/21/2007 | CN1931320A Medicinal wine composition and its prepn process |
| 03/21/2007 | CN1931318A Chines medicine composition for treating children rickets and other acalcicosis symptoms and its prepn process |
| 03/21/2007 | CN1931305A Aerosol for treating rheumatism and its prepn process |
| 03/21/2007 | CN1931304A Chinese medicine composition for treating osteoporosis and its prepn process |
| 03/21/2007 | CN1931298A Medicine for treating wind-damp arthralgia and hyperosteogeny |
| 03/21/2007 | CN1931295A Wind dispelling spray and its prepn process |
| 03/21/2007 | CN1931280A Medicine for treating osteoporosis and its prepn process |
| 03/21/2007 | CN1931277A Osteoarthrosis treating Chinese medicine composition and its prepn process |
| 03/21/2007 | CN1931251A Analgesic medicine composition and its prepn process and application |
| 03/21/2007 | CN1931245A Medicine for treating gouty arthritis and its prepn process and application |
| 03/21/2007 | CN1931221A Medicinal wine for treating traumatic injury |
| 03/21/2007 | CN1931213A Tuniclike psammosilene root extract and its prep. medicine composition and use |
| 03/21/2007 | CN1931187A Application of high purity and high adsorption nanometer microporous charcoal powder in preparing medicine for treating uric acid disease |
| 03/21/2007 | CN1931184A Massive dose calcium replenisher tablet for treating hyperosteogeny and its prepn |
| 03/21/2007 | CN1931159A Superfine Iguratimod powder and quick released oral prepn |
| 03/21/2007 | CN1931126A Garlic face mask |
| 03/21/2007 | CN1305906C Use of antibodies against specific MHC-Peptide complexes |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305489C Rheumatism treating plaster with 'Miao' ethnic drug Heiguteng and preparation process thereof |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192938 Orally administered risedronic acid or salt for osteoporosis or bone disorder treatment |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |